☰

Phillip H. Abbosh, Ph.D. - Publications

Affiliations: 
2006 Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Cell Biology, Molecular Biology, Biochemistry
Tree Info Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Gokare P, Finnberg NK, Abbosh PH, Dai J, Murphy ME, El-Deiry WS. P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting. Scientific Reports. 7: 9711. PMID 28851987 DOI: 10.1038/S41598-017-09859-X  0.306
2008 Abbosh PH, Zhang S, Maclennan GT, Montironi R, Lopez-Beltran A, Rank JP, Baldridge LA, Cheng L. Germ cell origin of testicular carcinoid tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1393-6. PMID 18316560 DOI: 10.1158/1078-0432.Ccr-07-4146  0.307
2008 Abbosh PH, Wang M, Eble JN, Lopez-Beltran A, Maclennan GT, Montironi R, Zheng S, Pan CX, Zhou H, Cheng L. Hypermethylation of tumor-suppressor gene CpG islands in small-cell carcinoma of the urinary bladder. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 21: 355-62. PMID 18192966 DOI: 10.1038/Modpathol.3801012  0.388
2007 Abbosh PH, Li X, Li L, Gardner TA, Kao C, Nephew KP. A conditionally replicative, Wnt/beta-catenin pathway-based adenovirus therapy for anaplastic thyroid cancer. Cancer Gene Therapy. 14: 399-408. PMID 17218945 DOI: 10.1038/Sj.Cgt.7701024  0.578
2006 Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH, Huang TH, Nephew KP. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Research. 66: 11954-66. PMID 17178894 DOI: 10.1158/0008-5472.Can-06-1666  0.499
2006 Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, Moseman AP, Golas A, Brannon KM, Balch C, Huang TH, Nephew KP. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Cancer Research. 66: 5582-91. PMID 16740693 DOI: 10.1158/0008-5472.Can-05-3575  0.49
2005 Abbosh PH, Nephew KP. Multiple signaling pathways converge on beta-catenin in thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 15: 551-61. PMID 16029121 DOI: 10.1089/Thy.2005.15.551  0.528
2004 Abbosh PH, Nephew KP. 452. Adenoviral Gene Therapy Using CRAd Targeted to Cells with Hyperactive Wnt/|[beta]|-Catenin Signaling Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.404  0.549
Show low-probability matches.